Thromb Haemost 1985; 53(01): 051-055
DOI: 10.1055/s-0038-1661235
Original Article
Schattauer GmbH Stuttgart

Standardization of β-Thromboglobulin (β-TG) and Platelet Factor 4 (PF4): A Collaborative Study to Establish International Standards for β-TG and PF4

P J Kerry
The National Institute for Biological Standards and Control, London, UK
,
A D Curtis
The National Institute for Biological Standards and Control, London, UK
› Author Affiliations
Further Information

Publication History

Received 30 July 1984

Accepted 31 October 1984

Publication Date:
18 July 2018 (online)

Summary

An international collaborative study was carried out to determine the suitability of freeze-dried preparations of β-TG and PF4 to serve as international standards, and to compare these materials with other purified preparations and with plasma samples. Although problems remain with the accurate measurement of these proteins, it has been demonstrated that common standards improve the precision of measurement by RIA and provide an essential foundation for future work into the effects of assay system differences.

The World Health Organization established in 1984 the purified preparation of β-TG (83/501) and the purified preparation of PF4 (83/505) as International Standards, with assigned potencies of 500 International Units per ampoule and 400 International Units per ampoule, respectively.

 
  • References

  • 1 Handin RI, McDonough M, Lesch M. Elevation of platelet factor 4 in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med 1978; 91: 340-349
  • 2 Kaplan KL. Platelet granule proteins: localization and secretion. In: Platelets in Biology and Pathology. Gordon JL. (ed) Elsevier/North Holland Biomedical Press; Amsterdam: 1981. 2 77-90
  • 3 Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
  • 4 Niewiarowski S. Platelet granule proteins with mitogenic and antiheparin activity. In: Platelets in Biology and Pathology. Gordon JL. (ed) Elsevier/North Holland Biomedical Press; Amsterdam: 1981. 2 92-106
  • 5 Dawes J, Pumphrey CW, McLaren KM, Prowse CV, Pepper DS. The in vivo release of human platelet factor 4 by heparin. Thromb Res 1982; 27: 65-76
  • 6 Ludlam CA, Bolton AE, Moore S, Cash JD. New rapid method for diagnosis of deep venous thrombosis. Lancet 1975; 2: 259-260
  • 7 Smith RC, Duncanson J, Ruckley CV, Webber RG, Allan NC, Dawes J, Bolton AE, Hunter WM, Pepper DS, Cash JD. β- thromboglobulin and deep vein thrombosis. Thromb Haemostas 1978; 39: 338-345
  • 8 de Boer AC, Han P, Turpie AG G, Butt R, Zielinsky A, Genton E. Plasma and urine β-thromboglobulin concentration in patients with deep vein thrombosis. Blood 1981; 58: 693-698
  • 9 Curtis AD, Kerry PJ. Standardization of β-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins. Thromb Haemostas 1983; 50: 686-689
  • 10 Ludlam CA, Cash JD. Studies on the liberation of β-thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247
  • 11 Campbell PJ. International biological standards and reference preparations II: Procedures used for the production of biological standards and reference preparations. J Biol Stand 1974; 2: 259-267
  • 12 Finney DJ. Statistical Method in Biological Assay, 3rd edit. Griffin & Co Ltd; London: 1978
  • 13 Gaines Das RE, Tydeman MS. Iterative weighted regression analysis of logit responses. A computer program for analysis of bioassays and immunoassays Comput Programs Biomed 1980; 15: 13-22
  • 14 Kirkwood TB L. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-909
  • 15 Kirkwood TB L. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742